End-of-day quote
Shenzhen S.E.
18:00:00 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
11.38
CNY
|
-0.70%
|
|
-3.15%
|
-24.49%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
15,041
|
25,961
|
16,243
|
10,596
|
9,230
|
6,906
|
-
|
-
|
Enterprise Value (EV)
1 |
15,041
|
25,961
|
16,243
|
10,596
|
9,230
|
6,906
|
6,906
|
6,906
|
P/E ratio
|
28.6
x
|
32.7
x
|
17
x
|
14.9
x
|
29.5
x
|
16.1
x
|
12.8
x
|
10.5
x
|
Yield
|
0.7%
|
-
|
-
|
-
|
1.03%
|
3.08%
|
4.48%
|
5.8%
|
Capitalization / Revenue
|
4.67
x
|
7.01
x
|
4.08
x
|
2.94
x
|
3.19
x
|
2.26
x
|
2.04
x
|
1.83
x
|
EV / Revenue
|
4.67
x
|
7.01
x
|
4.08
x
|
2.94
x
|
3.19
x
|
2.26
x
|
2.04
x
|
1.83
x
|
EV / EBITDA
|
17.6
x
|
21.7
x
|
11.2
x
|
9.86
x
|
-
|
8.6
x
|
7.22
x
|
6.16
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
221
x
|
62.8
x
|
19.8
x
|
11.5
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
0.45%
|
1.59%
|
5.04%
|
8.69%
|
Price to Book
|
4.81
x
|
6.84
x
|
3.78
x
|
1.68
x
|
1.45
x
|
1.03
x
|
0.97
x
|
0.9
x
|
Nbr of stocks (in thousands)
|
557,699
|
557,109
|
556,470
|
612,470
|
612,470
|
606,828
|
-
|
-
|
Reference price
2 |
26.97
|
46.60
|
29.19
|
17.30
|
15.07
|
11.38
|
11.38
|
11.38
|
Announcement Date
|
2/24/20
|
2/25/21
|
4/19/22
|
4/24/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,223
|
3,704
|
3,981
|
3,608
|
2,896
|
3,059
|
3,377
|
3,778
|
EBITDA
1 |
854.8
|
1,198
|
1,450
|
1,074
|
-
|
803.4
|
956.5
|
1,122
|
EBIT
1 |
695.8
|
989.7
|
1,214
|
817.4
|
331.1
|
497.4
|
620.2
|
753.4
|
Operating Margin
|
21.59%
|
26.72%
|
30.5%
|
22.65%
|
11.44%
|
16.26%
|
18.36%
|
19.94%
|
Earnings before Tax (EBT)
1 |
693.2
|
969.8
|
1,187
|
789.1
|
305.4
|
471.9
|
594.6
|
728.3
|
Net income
1 |
525.3
|
793.9
|
956.6
|
708
|
312.6
|
433.6
|
544.3
|
664.4
|
Net margin
|
16.3%
|
21.43%
|
24.03%
|
19.62%
|
10.8%
|
14.18%
|
16.12%
|
17.58%
|
EPS
2 |
0.9418
|
1.424
|
1.718
|
1.165
|
0.5104
|
0.7067
|
0.8900
|
1.087
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
41.78
|
110
|
348
|
600
|
FCF margin
|
-
|
-
|
-
|
-
|
1.44%
|
3.6%
|
10.3%
|
15.88%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
13.69%
|
36.38%
|
53.48%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
13.37%
|
25.37%
|
63.94%
|
90.31%
|
Dividend per Share
2 |
0.1890
|
-
|
-
|
-
|
0.1550
|
0.3500
|
0.5100
|
0.6600
|
Announcement Date
|
2/24/20
|
2/25/21
|
4/19/22
|
4/24/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
41.8
|
110
|
348
|
600
|
ROE (net income / shareholders' equity)
|
18%
|
22.9%
|
23.1%
|
12.1%
|
4.94%
|
6.41%
|
7.74%
|
8.73%
|
ROA (Net income/ Total Assets)
|
10.5%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
5,026
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
5.610
|
6.820
|
7.720
|
10.30
|
10.40
|
11.00
|
11.70
|
12.60
|
Cash Flow per Share
2 |
0.8200
|
1.960
|
2.910
|
1.380
|
-
|
0.9700
|
1.260
|
1.450
|
Capex
1 |
503
|
498
|
600
|
967
|
860
|
695
|
517
|
403
|
Capex / Sales
|
15.62%
|
13.43%
|
15.07%
|
26.81%
|
29.69%
|
22.72%
|
15.31%
|
10.68%
|
Announcement Date
|
2/24/20
|
2/25/21
|
4/19/22
|
4/24/23
|
4/24/24
|
-
|
-
|
-
|
Last Close Price
11.38
CNY Average target price
15.46
CNY Spread / Average Target +35.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -24.49% | 950M | | -11.78% | 11.24B | | -13.76% | 7.29B | | +29.50% | 5.57B | | -19.19% | 3.68B | | +7.62% | 2.58B | | -65.24% | 2.33B | | -10.48% | 2.23B | | +27.80% | 2.21B | | -19.12% | 1.57B |
Diagnostic & Testing Substances
|